Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)

NCT00782834 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Stopped early for futility, unable to meet accrual goals

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Nilotinib

Sponsor

Fox Chase Cancer Center